咨询热线:010-85111156
首页 >医学专区 > 医学SCI杂志 > Clinical Drug Investigation

医学SCI杂志

联系我们

电话:010-85111156
手机:15210945929
QQ:37750280
QQ:55017753

Clinical Drug Investigation

发布时间2012-11-12 21:07:16 浏览:3943
Clinical Drug Investigation Editor-in-Chief: Jasbir Singh, MBChB, MS, PG Cert (PH) ISSN: 1173-2563 Online ISSN: 1179-1918 Frequency: 12 issues a year Impact Factor: 1.822 Subscribe: Subscribe
Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1173-2563.

Clinical Drug Investigation gives you rapid access to the best designed, peer reviewed clinical and pharmacoeconomic studies worldwide, allowing you to keep up to date with the latest original research in this exciting area. The Journal's aim is rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. This includes clinical trials, outcomes research, clinical pharmacoeconomic studies, pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs, clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice and, in some instances, pharmacodynamic or pharmacokinetic studies in healthy volunteers, but in which some established or purported implications for clinical prescribing are discussed. In addition, short communications and case study reports that meet these criteria are also encouraged, as are letters to the editor.

Editor-in-Chief: Jasbir Singh, MBChB, MS, PG Cert (PH)
ISSN: 1173-2563
Online ISSN: 1179-1918
Frequency: 12 issues a year
Impact Factor: 1.822
Subscribe: Subscribe

web site:http://adisonline.com/druginvestigation/Pages/default.aspx

首页 | 法律声明 | 广告服务 | 免责条款 | 合作机构 | >5000 |
Copyright © 2010-2018 www.kotoon.com All rights reserved. 科通编译--EI/SCI论文翻译论文咨询,图书出版,专利转让 京ICP备17032720号 技术支持:易网天成
点击这里给我发消息 点击这里给我发消息